USP24 suppresses T cell anti-tumor activity by enhancing the stability of the PD-1 protein

被引：0
|
作者：
Hsieh, Hung-Chia
Hung, Jan-Jong
Wang, Yi-Ching
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB445
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Enhancing anti-tumor efficacy of MART-1-specific TCR-T cells by CRISPR-Cas9-based PD-1 disruption
    Gao, Qianqian
    Ding, Renpeng
    Chen, Huanyi
    Xu, Qumiao
    Zhu, Linnan
    Dong, Xuan
    Gu, Ying
    Chao, Cheng-chi
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
    Piasecki, Julia
    Le, Tiep
    Ponce, Rafael
    Beers, Courtney
    CANCER RESEARCH, 2015, 75
  • [43] Enhancement of anti-tumor effects of PD-1 inhibitors by modulation of lipid metabolism in tumor microenvironment
    Katoh, Yuki
    Yaguchi, Tomonori
    Iwata, Takashi
    Kawana, Kei
    Kawakami, Yutaka
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 148 : 1 - 2
  • [44] Dual inhibition of PD-1 and LAG-3: uncovering mechanisms to reverse T cell exhaustion and enhance anti-tumor immunity
    Zhou, Xiaoxue
    Zhou, Fangfang
    Zhang, Long
    SCIENCE BULLETIN, 2025, 70 (05) : 624 - 626
  • [45] Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells
    Okada, Masahiro
    Chikuma, Shunsuke
    Kondo, Taisuke
    Hibino, Sana
    Machiyama, Hiroaki
    Yokosuka, Tadashi
    Nakano, Miyako
    Yoshimura, Akihiko
    CELL REPORTS, 2017, 20 (05): : 1017 - 1028
  • [46] PD-1 silencing improves anti-tumor activities of human mesothelin-targeted CAR T cells
    Liu, Guodi
    Zhang, Qian
    Li, Dehua
    Zhang, Linsong
    Gu, Zhangjie
    Liu, Jibin
    Liu, Guoping
    Yang, Mu
    Gu, Jinwei
    Cui, Xingbing
    Pan, Yingjiao
    Tian, Xiaoli
    HUMAN IMMUNOLOGY, 2021, 82 (02) : 130 - 138
  • [47] Enhancing the Efficacy of Anti-tumor Immunotherapy by Targeting T cell Metabolism
    Xin Pei Ji
    Qiu Yan Liu
    JournalofNutritionalOncology, 2019, 4 (02) : 67 - 73
  • [48] Incorporation of SKI-G-801, novel AXL inhibitor, with anti-PD-1 inhibitor plus chemotherapy improved anti-tumor activity and survival outcome via enhancing anti-tumor T cell immunity.
    Pyo, Kyoung-Ho
    Lee, Wongeun
    Lee, Hee Kyu
    Kim, Dong Kwon
    Jo, Ha Ni
    Synn, Chun-Bong
    Kim, Jae Hwan
    Byeon, Yeongseon
    Kim, Young Seob
    Ahn, Beung-Chul
    Hong, Min Hee
    Lim, Sun Min
    Cho, Byoung Chul
    Kim, Hye Ryun
    CANCER RESEARCH, 2021, 81 (13)
  • [49] PD-1 Tumor Suppressor Signaling in T Cell Lymphomas
    Wartewig, Tim
    Ruland, Juergen
    TRENDS IN IMMUNOLOGY, 2019, 40 (05) : 403 - 414
  • [50] Combining CD27 costimulation and PD-1 blockade into a bispecific antibody improves T cell activation and anti-tumor activity over combination of individual antibodies
    Vitale, Laura
    Thomas, Lawrence
    O'Neill, Thomas
    Widger, Jenifer
    Mills-Chen, Laura
    Crocker, Andrea
    Patterson, Colleen
    Wasiuk, Anna
    Forsberg, Eric
    Boyer, James
    Sisson, Crystal
    Weidlick, Jeffrey
    Renn-Bingham, Shannon
    Papayannopoulos, Ioannis
    Hammond, Russ
    Goldstein, Joel
    Marsh, Henry, Jr.
    He, Li-Zhen
    Yellin, Michael
    Keler, Tibor
    Keler, Tibor
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345